ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

MSKCC hopes to raise $1 billion in five-year campaign.

November 7, 2003

Obituary: Ruth Kirschstein, 82, NIH Administrator, Scientist, Mentor. House Member Softens Breast Cancer Bill

October 9, 2009

ACS Study Shows Reduced Mortality For Low T/N Brands

April 18, 1980

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

Radiation Doesn’t Add Benefit For Early Endometrial Cancer

June 29, 2007

NCAB forms subcommittee to develop NCI biomedical technologies initiative.

September 26, 2003